Intra-articular injections are a frontline treatment for equine joint disease but require careful welfare consideration in application and monitoring.
Equine joint injections occupy an ethically complex space: when used appropriately for genuine pathology, they provide pain relief that improves welfare by enabling comfortable movement. When used to suppress pain signals in horses being competed beyond their soundness capacity, they compromise welfare by enabling continued use of a horse who would otherwise show lameness that should prompt rest and treatment. The anti-doping and welfare regulatory challenge is distinguishing therapeutic injections from performance enhancement — a distinction that requires detailed veterinary records and honest communication between vets, trainers, and owners. Best practice involves injecting only clearly indicated joints with minimum effective doses, maintaining detailed records, and scheduling appropriate rest periods following injections to allow genuine healing rather than pain-masked continued work.